医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

MediMer: a versatile do-it-yourself peptide-receptive MHC class I multimer platform for tumor neoantigen-specific T cell detection.

广告
第一作者: Marten,Meyer
第一单位: Antigen Presentation and T/NK Cell Activation Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.;Clinical Cooperation Unit Applied Tumor Immunity, DKFZ, Heidelberg, Germany.;Department of Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg University Hospital, Heidelberg, Germany.
作者单位: Antigen Presentation and T/NK Cell Activation Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.;Clinical Cooperation Unit Applied Tumor Immunity, DKFZ, Heidelberg, Germany.;Department of Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg University Hospital, Heidelberg, Germany. [1] Antigen Presentation and T/NK Cell Activation Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. [2] Division of Immunotherapy and Immunoprevention, DKFZ, Heidelberg, Germany.;German Center for Infection Research (DZIF) Partner Site Heidelberg, Heidelberg, Germany. [3] Clinical Cooperation Unit Applied Tumor Immunity, DKFZ, Heidelberg, Germany.;Department of Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg University Hospital, Heidelberg, Germany.;Center for Quantitative Analysis of Molecular and Cellular Biosystems (Bioquant), Heidelberg University, Heidelberg, Germany. [4] Clinical Cooperation Unit Applied Tumor Immunity, DKFZ, Heidelberg, Germany. [5] Antigen Presentation and T/NK Cell Activation Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.;Department of Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg University Hospital, Heidelberg, Germany. [6] Antigen Presentation and T/NK Cell Activation Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.;Clinical Cooperation Unit Applied Tumor Immunity, DKFZ, Heidelberg, Germany. [7] Deep Sequencing Core Facility, Heidelberg University, Heidelberg, Germany. [8] Department of Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg University Hospital, Heidelberg, Germany.;GMP and T Cell Therapy, DKFZ, Heidelberg, Germany. [9] GMP and T Cell Therapy, DKFZ, Heidelberg, Germany. [10] Division of Immune Receptors and T Cell Activation, Center for Pathophysiology, Infectiology, Medical University of Vienna, Vienna, Austria. [11] Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, DKFZ, Heidelberg, Germany.;Immune Monitoring Unit, NCT Heidelberg and DKFZ, Heidelberg, Germany. [12] Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, DKFZ, Heidelberg, Germany.;Immune Monitoring Unit, NCT Heidelberg and DKFZ, Heidelberg, Germany.;German Cancer Consortium (DKTK), DKFZ, Core Center, Heidelberg, Germany.;Department of Neurology, Medical Faculty Mannheim, Mannheim Center for Translational Neuroscience (MCTN), Heidelberg University, Mannheim, Germany.;DKFZ Hector Cancer Institute at the University Medical Center, Mannheim, Germany.;Helmholtz Institute for Translational Oncology, Mainz (HI-TRON Mainz), Mainz, Germany. [13] German Cancer Consortium (DKTK), DKFZ, Core Center, Heidelberg, Germany.;Division of Translational Medical Oncology, NCT Heidelberg and DKFZ, Heidelberg, Germany.;Institute of Human Genetics, Heidelberg University, Heidelberg, Germany. [14] Section of DermatoOncology, Department of Dermatology and NCT, Heidelberg University Hospital, Heidelberg, Germany. [15] Clinical Cooperation Unit Applied Tumor Immunity, DKFZ, Heidelberg, Germany.;Department of Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg University Hospital, Heidelberg, Germany. [16]
DOI 10.3389/fimmu.2023.1294565
PMID 38239352
发布时间 2024-03-29
提交
  • 浏览0
Frontiers in immunology

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷